Hepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C Therapy

By D’Ambrosio Roberta   Della Corte Cristina   Colombo Massimo  

International Journal of Molecular Sciences, Vol. 16, Iss. 8, 2015-08 ,pp. : 19698-19712

MDPI

Access to resources Recommend Favorite

Polymorphisms of HLA-DM on Treatment Response to Interferon/Ribavirin in Patients with Chronic Hepatitis C Virus Type 1 Infection

By Chen Hongbo   Yao Yinan   Wang Yifan   Zhou Hua   Xu Tianxiang   Liu Jing   Wang Guocheng   Zhang Yongfeng   Chen Xiang   Liu Qingwei   Huang Peng   Yu Rongbin  

International Journal of Environmental Research and Public Health, Vol. 13, Iss. 10, 2016-10 ,pp. : 1030-1030

MDPI

Access to resources Recommend Favorite

A Better Antiviral Efficacy Found in Nucleos(t)ide Analog (NA) Combinations with Interferon Therapy than NA Monotherapy for HBeAg Positive Chronic Hepatitis B: A Meta-Analysis

By Wei Wei   Wu Qinmei   Zhou Jialing   Kong Yuanyuan   You Hong  

International Journal of Environmental Research and Public Health, Vol. 12, Iss. 8, 2015-08 ,pp. : 10039-10055

MDPI

Access to resources Recommend Favorite

Antiviral Therapy for Hepatitis C Virus: Beyond the Standard of Care

By Delang Leen   Coelmont Lotte   Neyts Johan  

Viruses, Vol. 2, Iss. 4, 2010-03 ,pp. : 826-866

MDPI

Access to resources Recommend Favorite

Ribavirin Levels and Haemoglobin Decline in Early Virological Responders and Non-Responders to Hepatitis C Virus Combination Therapy

By  

Pharmacology, Vol. 76, Iss. 3, 2006-02 ,pp. : 136-140

Karger

Access to resources Recommend Favorite